US Patent Issued to Sichuan Cancer Hospital on Oct. 21 for "Anti-CD79B protein monoclonal antibody, products containing the same, and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,449,421, issued on Oct. 21, was assigned to Sichuan Cancer Hospital (Chengdu, China).

"Anti-CD79B protein monoclonal antibody, products containing the same, and uses thereof" was invented by Tongyu Lin (Chengdu, China), Yang Liu (Chengdu, China), Zongyao Huang (Chengdu, China), Huangming Hong (Chengdu, China), Junxuan Zhu (Chengdu, China), Jun Hou (Chengdu, China), Dan Luo (Chengdu, China) and Jingcheng Luo (Chengdu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An anti-CD79B protein monoclonal antibody and related products and uses thereof are disclosed. The anti-CD79B protein monoclonal antibody comprises a heavy chain and a light chain, wherei...